TuttoCongressi
E-mail
Password
Resta Collegato

Cerca per parole nell'archivio:


In archivio:
  • N° Relazioni: 53187
  • N° Accessi Relaz.: 121706
Web Video
Portale Giovani Medici

   home   |   progetto   |   chi siamo   |   servizi   |   contatti   |   note legali Live Demo

ISGE 2006

 
02/03/2006 - 05/03/2006
 
Relazioni: 224
Programma Evento
Info
   Mostra tutti | Mostra contenuti EasyRec   
02/03/2006
Auditorium
11:00 - 13:00
POSSIBILITIES & CHALLENGES WITH ORAL CONTRACEPTION
Fruzzetti F. 
Menstrual cycle suppression
Skouby S. 
Epidemiology and treatment of PMS/PMDD
Busacca M. 
Epidemiology and treatment of endometriosis and pelvic pain
Maudelonde T. 
Non-contraceptive benefits of oral contraceptives
14:00 - 16:00
THE ROLE OF EFFICACY, SAFETY AND COST IN ART: CHOICE OF THE GONADOTROPHINS
Cortvrindt R. 
Bioactivity of the HP urinary FSH (Fostimon®) versus the recombinant FSH (Gonal-F®) evaluated by the Follicle Bioassay
Iammarrone E. 
Cost influences the choice of gonadotrophins (urinary versus recombinant) used in ART treatment in the United Kingdom
Urbancsek J. 
What's the principle for selecting u-FSH or r-FSH in ART: recent clinical evidences in women undergoing controlled ovarian stimulation for IntraCytoplasmic Sperm Injection (ICSI)
Diedrich K. 
The choice between recombinant versus urinary gonadotrophins - impact on IVF-treatment costs in Germany
De Mouzon J. 
In vitro fertilization in France: economic aspects and influence of the gonadotrophin choice (urinary versus recombinant) on cost
 
Onice
11:00 - 13:00
ORAL PRESENTATIONS - CURRENT RESEARCH IN INFERTILITY AND ENDOMETRIOSIS
Bagchi C. 
Endothelin-2, a progesterone-regulated paracrine factor in mouse ovary, plays a critical role in ovulation
Alviggi C. 
A common genetic variant of LH b-subunit and controlled ovarian stimulation: retrospective study of prevalence in women with different profiles of follicular growth
Grygielko E. 
Pharmacological validation and transcriptional analyses of preclinical models of estrogen opposition
Salata I. 
Serum Concentrations of Matrix Metalloproteinases (MMP-2, MMP-9) And Their Inhibitors (TIMP-1, TIMP-2) Do Not Reflect The Severity of Endometriosis
Goulis D.G. 
Reduced levels of inhibin-B and correlation with testicular cytology in subfertile men
Goulis D. 
The use of Data Mining in the categorization of patients with azoospermia
Nabhan A. 
Correlation between Hormonal Markers of Ovarian Reserve and the Antral Follicle Count
14:00 - 16:00
SPECIAL SYMPOSIUM SOBRAGE - EXTENDED USE OF HORMONAL CONTRACEPTION
Bonassi R. 
The concept of extended use of hormonal contraception
Geribela A. 
Clinical acceptability of extended use of hormonal contraception
Spinola P. 
Clinical acceptability of injectable contraceptives
Hugo M. 
Local estrogen production, uterine pathology and treatment using extended use of hormonal contraceptives
17:00 - 19:00
ORAL PRESENTATIONS - MENOPAUSE IN 2006
Muscat Baron Y. 
Intervertebral Disc Height in Postmenopausal Women with Osteoporotic Vertebral Fractures
Nijland E. 
Effects of tibolone and continuous combined estrogen-progestin therapy (ept) on quality of life and sexual function
Wildemeersch D. 
Maximizing the benefits and acceptability of HRT while reducing the risk to a minimum: an easily applicable solution for a major public health problem
Virtej I. 
Subclinical hypothyroidism in postmenopausal women ? effects on plasma lipid profile are modified by insulin resistance
Vujovic S. 
Premenstrual syndrome, sexuality and premature ovarian failure
Di Carlo C. 
Postmenopausal hypoestrogenism increases vasoconstricting and decreases vasodilatory neuropeptides content in the arterial wall autonomic terminations
Caruso S. 
Steroids, olfaction and sexuality
 
PalazzoAffari
11:00 - 13:00
THE MENOPAUSAL BRAIN
Rossmanith W. 
The human menopause - a primary neuroendocrine event?
Genazzani A. 
Neurosteroid synthesis and action in the menopausal brain
Maki P. 
CNS structure and function after the menopause
14:00 - 16:00
NOVO NORDISK SATELLITE SYMPOSIUM - LOCAL OESTROGENS: QUO VADIS?
Archer D. 
Evolving evidence useful for counseling on Hormone Therapy
Ulrich L. 
Symptoms and treatment of local estrogen deficiency
Guidozzi F. 
Atrophic vaginitis: a growing problem?
Nappi R. 
Sexual dysfunction in long term users of oral contraceptives
16:20 - 16:50
PLENARY LECTURE - BRUNO LUNENFELD: THE ANDROGEN DEFICIENCY SYNDROME IN THE AGING MALE
Lunenfeld B. 
The androgen deficiency syndrome in the aging male
17:00 - 19:00
MOLECULAR ENDOCRINOLOGY: CLINICAL IMPACT
Diaz Brinton R. 
Estrogens and The Brain: Healthy Cell Bias of Estrogen Action
Simoncini T. 
How steroid signaling in vascular cells predicts the clinical effects of HRT
Thijssen J. 
Progesterone receptors in the human
 
Verde
11:00 - 13:00
OVARIAN DEVELOPMENT, MATURITY AND AGING
Leung P. 
Multi-faceted role of GnRH1 and 2 in the human ovary
Pangas S. 
TGFbeta Superfamily Regulation of Ovarian Folliculogenesis
Barri P. 
Reproduction of the ageing patient
14:00 - 16:00
THE BONE AS A TARGET OF REPRODUCTIVE HORMONES
Gambacciani M. 
Hormonal contraception and bone health
Christiansen C. 
Bone health after the menopause and hormone replacement therapy
16:20 - 16:50
MELBROSIN SPONSORED LECTURE - MARTIN IMHOF
Imhof M. 
Clinical action and safety of red clover isoflavones
 
03/03/2006
Auditorium
08:30 - 10:00
SPECIAL SESSION - MENOPAUSE HORMONE THERAPY BEYOND WHI
Gambacciani M. 
Is ERT/HRT an option for prevention and treatment of Osteoporosis after WHI
Brincat M. 
Significance of changes in connective tissue with the menopause and with HRT
Genazzani A.R. 
New HRT Options for the Treatment of Menopausal Symptoms and the Maintenance of Quality of Life in Postmenopausal Women
10:10 - 10:40
PLENARY LECTURE - RICHARD FARMER: CAN HRT BE REHABILITATED?
Farmer R. 
Can HRT be rehabilitated?
11:00 - 13:00
ORGANON SATELLITE SYMPOSIUM - TIBOLONE: NEW RESULTS FROM KEY CLINICAL TRIALS
Morris E. 
Tibolone versus estrogen-progestin therapy ? what has been investigated so far?
Hammar M. 
A randomized comparative study with tibolone and a low dose continuous combined estrogen-progestin therapy (EPT)
Adami S. 
Effects of tibolone and raloxifene on bone: results of the step study
14:00 - 16:00
SOLVAY SATELLITE SYMPOSIUM - LONG TERM BENEFITS AND RISKS OF FEMOSTON
Simoncini T. 
Are progestins all the same? Lessons from the vascular system
Stevenson J. 
Oestradiol 17β plus cyclical dydrogesterone HRT and its effect on lipid parameters
Berga S. 
The Brain as a Target Tissue of Sex Steroids
 
Onice
08:30 - 10:00
ORAL PRESENTATIONS - RECENT PROGRESSES IN CONTRACEPTION
Rad M. 
Effects on risk markers for venous and arterial disease and on estrogenicity markers of a vaginal ring delivering Nesterone and ethinyl estradiol in comparison with a combined oral contraceptive containing levonorgestrel
Kluft C. 
Hemostasis effects of oral contraceptives containing drospirenone in combination with either 30 or 20 µg ethinylestradiol and a reference containing desogestrel and 30 µg ethinyl estradiol
Rad M. 
Metabolic Effects of the Continuous Use of a Low-dose Levonorgestrel (LNG)/Ethinyl Estradiol (EE) Oral Contraceptive (OC) in a Randomized Study
Schilling A. 
The efficacy and safety of ethinylestradiol/chlormadinone acetate (Belara®): Results of a non-interventional trial in four Latin-American countries
Gruber D. 
Cycle control of two 21-day COC regimens, both containing ethinyloestradiol 20µg one with drospirenone 3mg and one with desogestrel 150µg
Rajaei L. 
Evaluation of side effects of low dose contraceptive pills administered by the vaginal route
11:00 - 13:00
SPECIAL SYMPOSIUM - THE EUROPEAN SOCIETY OF GYNAECOLOGY: HORMONAL ASPECTS OF BREAST CANCER (INTERACTIVE, CASE BASED SYMPOSIUM)
Calaf J. 
Sismondi P. 
.
Ylikorkala O. 
Clotet M. 
Espiè M. 
Pellissier C. 
14:00 - 16:00
ORAL PRESENTATIONS - FRONTIERS IN CANCER RESEARCH
Hill S. 
Estrogen Receptor Transactivation Regulation By Melatonin Involves In G Protein Coupled Signal Transduction Pathway In Endometrial Cancer
Choi J. 
Gonadotropins: the role and molecular mechanism in normal and neoplastic ovarian epithelium cells
Tsigkou A. 
Inhibin alpha, a new serum marker for prostate cancer?
Martineti V. 
Action of two isoflavonoids on human HCT8 colon cancer cell lines over-expressing ERb
Cosio S. 
Is p53 gene status a predictive or prognostic variable for patients with poorly differentiated, advanced serous epithelial ovarian cancer treated with paclitaxel- plus platinum-based chemotherapy ?
17:00 - 19:00
SPECIAL SYMPOSIUM EN LANGUE FRANÇAISE - SOCIÉTÉ FRANCOPHONE DE CONTRACEPTION (SOUS RÉSERVE D'ACCORD DES INTERVENANTS): CONTRACEPTION - INNOVATIONS ET INTERROGATIONS
Sitruk Ware R. 
Implants contraceptifs pour homme et pour femme
Bouchard P. 
Les anti-progestérones de nouvelle génération : leur intérêt en contraception
Serfaty D. 
Le CIRC (Centre International de Recherche contre le Cancer) et la cancérogénécité de la pilule
Bitzer J. 
 
PalazzoAffari
08:30 - 10:00
PRE-MENSTRUAL SYNDROME, POST-NATAL AND POST-MENOPAUSAL DEPRESSION AND OTHER HORMONE-RELATED DYSPHORIC DISORDERS
Facchinetti F. 
Premenstrual changes: towards a different approach
Studd J. 
Hormonal treatment of severe premenstrual syndrome
Nappi R. 
Post-partum depression
10:10 - 10:40
PLENARY LECTURE - SARAH BERGA: THE ROLE OF THE CENTRAL NERVOUS SYSTEM IN THE PATHOGENESIS OF POLYCYSTIC OVARY SYNDROME
Berga S. 
The role of the central nervous system in the pathogenesis of polycystic ovary syndrome
11:00 - 13:00
GENOMIC AND PROTEOMIC APPROACHES TO THE DIAGNOSIS AND TREATMENT OF GYNECOLOGICAL CANCER
Tsang B. 
Deciphering the molecular and cellular mechanisms of chemoresistant ovarian cancer
Konishi I. 
Molecular genetics in the development of the two types of endometrial carcinoma
Faragher R. 
Microarray analysis of replicative senescence
Kalogeropoulos S. 
Telomerase Activity, Telomere Length and Degree of Aneuploidy in Ovarian Adenocarcinomas
14:00 - 16:00
HYPERINSULINEMIA AND INSULIN RESISTANCE: A CHALLENGE IN GYNECOLOGICAL ENDOCRINOLOGY
Goverde A. 
Consequence of hyperinsulinemia in anovulatory PCOS
Skouby S. 
Steroid hormone use in insulin resistant women: clinical issues
Benedetto C. 
Insulin sensitizing agents during pregnancy
Angioni S. 
Ovarian stromal hypertrophy and insulin abnormalities in pcos
16:20 - 16:50
ROTTAPHARM SPONSORED LECTURE - A CATAPANO: DYSLIPOPROTEINEMIAS: DIETARY & NUTRITIONAL APPROACHES
Catapano A. 
Dyslipoproteinemias: dietary & nutritional approaches
17:00 - 19:00
THE OBESE PATIENT CLINICAL ISSUES IN REPRODUCTIVE ENDOCRINOLOGY
Niswender K. 
Biological and evolutionary basis of body weight homeostasis
Creatsas G. 
Menstrual cycle disorders in the PCO obese adolescents
Marconi A. 
The obese patient during pregnancy
Milewicz A. 
Clinical implications of obesity after the menopause
Fulghesu A. 
Endocrine and metabolic aspects in obese and lean young PCOS
 
Quattro
11:00 - 13:00
ORAL PRESENTATIONS - CLINICAL ISSUES IN GYNECOLOGICAL ENDOCRINOLOGY
Loverro G. 
Inhibitory effect of obesity on gonadotropin, estradiol and inhibin b levels in fertile women
Crivelli M. 
Hiv infection, stress and reproduction
Garcia M. 
Decreased Subjective and Objective Measurements of Sexual Function and Testosterone Levels in Hypopituitary Women
Naessén S. 
Endocrine and nutrition-related determinants of bone mineral density in bulimic women
Tropea A. 
Androgens decrease vegf expression and secretion in human luteal cells
Dabkowska-Huc A. 
The influence of endogenous testosterone on the gene expression for 5-a-reductase type 1 and 2 in hair papillae from lower abdominal region of the skin among women with hirsutism
Romualdi D. 
Effect of pioglitazone treatment on the adrenal androgen response to corticotrophin in obese patients with polycystic ovary syndrome
De Falco M. 
Preoperative treatment of uterine leiomyomas: clinical findings and expression of TGF-β3 and CTGF
14:00 - 16:00
ORAL PRESENTATIONS - FROM GAMETES TO PREGNANCY: ART IN 2006
Cheong M. 
Analysis of human telomerase reverse transcriptase (hTERT) mRNA expressions in the endometrim of endometriosis
Campo S. 
Short-term and long-term results of laparoscopic surgery of endometriomas
Yadav RK. 
Serum leptin levels in pelvic endometriosis: An Indian experience
Soares A. 
Effects of coasting on assisted reproduction outcome
Lockwood G. 
Optimising outcome of IVF-ET treatment cycles in ?poor responders'
 
Verde
08:30 - 10:00
PUBERTY AND PRIMARY AMENORRHEA
Apter D. 
Normal and abnormal pubertal development: clinical and hormonal assessment
Baroncelli G. 
Strategies to improve skeletal development in girls and adolescents with abnormal pubertal development
Bruni V. 
Clinical treatment to improve the reproductive phenotype in abnormal pubertal development and in women with primary amenorrhea
Ben-Rafael Z. 
Pregnancy in Turner syndrome and gonadal dysgenesis: strategies and therapies
10:10 - 10:40
PLENARY LECTURE - LISELOTTE METTLER: OVARIAN SURGERY AND FOLLICULAR RESERVE
Mettler L. 
Ovarian surgery and follicular reserve
11:00 - 13:00
REPRODUCTIVE SURGERY
Garcia Velasco J. 
Ovarian drilling: a critical review
Gargiulo T. 
Symptomatic pelvic congestion syndrome: surgical management
14:00 - 16:00
HORMONES AND ENDOMETRIOSIS
Petraglia F. 
Hormonal treatments and endometriosis
Taylor R. 
Nuclear receptor actions in endometriosis
Schindler A. 
Mode of application of GnRH agonists for the treatment of endometriosis
Lanzone A. 
Paracrine regulation of endometriotic tissue
Cela V. 
Management of surgically treated endometriosis patients
17:00 - 19:00
GENETIC VARIABILITY IN GYNECOLOGICAL ENDOCRINOLOGY
Huber J. 
The impact of genetic variability and gynecological endocrinology
Brandi M. 
Genetics of Osteoporosis
Di Blasio A. 
Genetic factors related to endometriosis
Herrington D. 
Pharmacogenomics of hormone replacement therapy
Pertynski T. 
Antigen levels of matrix metalloproteinase 1 and its gene polymorphisms and endometrial bleeding in hormone replacement therapy users
 
04/03/2006
Auditorium
08:30 - 10:00
SPECIAL SESSION - NEW ADVANCES IN MENOPAUSE RESEARCH
Wuttke W. 
Black cohosh for the treatment of climacteric complaints and osteoporosis
Tian Q. 
Long-term low-dose HRT protects the cardiovascular system in post-menopausal women
10:10 - 10:40
ROTTAPHARM SPONSORED LECTURE - ALESSANDRA GRAZIOTTIN: NEW ADVANCES IN PHYTOESTROGENS THERAPY
Graziottin A. 
New advances in phytoestrogens therapy
11:00 - 13:00
MERCK THERAMEX SPONSORED SYMPOSIUM - ADVANTAGES OF CONTINUOUS COMBINED TRANSDERMAL HORMONAL THERAPY
Genazzani A. 
The impact of transdermal hormone administration on CNS
Speroff L. 
Transdermal vs Oral Postmenopausal Hormone Therapy. Is There a Clinical Difference?
 
Onice
08:30 - 10:00
SPECIAL SYMPOSIUM SIGITE - EPIDEMIOLOGY OF MENOPAUSE IN ITALY: FINDINGS FROM PROGETTO MENOPAUSA ITALIA
Lello S. 
Depression during menopausal transition
Parazzini F. 
Epidemiology of menopause and hormonal treatment
Becorpi A. 
Lowbone density and osteoarthritis in postmenopausal women
Baldi S. 
Cardiovascular riskfactors and menopause
11:00 - 13:00
SPECIAL SYMPOSIUM ISPOG - WHEN AND WHY FOR A PSYCHOSOMATIC APPROACH IN GYNECOLOGY
Peters A. 
Psychosocial factors on the course of pre malignant cervical lesions
Bitzer J. 
Menopausal medicine and psychosomatics - challenges and link
Damonte C. 
Quality of life in menopause: is it possible to quantify?
Horner E. 
Recent and future advances in the treatment of premenstrual syndrome
14:00 - 16:00
SPECIAL SYMPOSIUM OGASH - INTERCONTINENTAL SOCIETY FOR THE STUDY OF GESTOSIS
El-Kabarity H. 
Feto-Maternal Immunologic Dialogue Part II Humeral and Cellular immunologic response in EPH-Gestosis
Cosmi E. 
The role of hormones on fetal lung maturity (FLM)
17:00 - 19:00
SPECIAL SYMPOSIUM POLISH GYNECOLOGIC SOCIETY
Drews K. 
Hormonal and genetic screening ? new insights in pregnancy and preterm birth
Jakimiuk A. 
Endocrine aspects of dysfunctional uterine bleeding (DUB): etiopathology and treatment
Paszkowski T. 
Future of HRT - how far can we go down with the dose?
 
PalazzoAffari
08:30 - 10:00
UTERINE MYOMAS: BIOLOGICALLY-DRIVEN THERAPEUTICAL APPROACHES
Di Carlo C. 
Newer approaches for the treatment of uterine myomas
Mettler L. 
Comparison of surgical treatments of fibroids
10:10 - 10:40
SOLVAY SPONSORED LECTURE - JULIA SZEKERES-BARTHO: HOW DO THE IMMUNOLOGICAL ASPECTS OF DYDROGESTERONE IMPACT NORMAL PREGNANCY?
Szekeres-Bartho J. 
How do the immunological aspects of dydrogesterone impact normal pregnancy?
11:00 - 13:00
EMBRYO DEVELOPMENT, IMPLANTATION AND EARLY PREGNANCY LOSS
Dey S. 
Molecular roadmap to embryo implantation
Yeung W. 
Complement protein 3 - an oviductal paracrine factor regulating embryo development
14:00 - 16:00
AMSA/IBSA SATELLITE SYMPOSIUM - PROGESTERONE USE IN REPRODUCTIVE MEDICINE: LOOKING FOR THE BEST WAY OF ADMINISTRATION
De Ziegler D. 
Progesterone benefits in IVF cycles: an issue of dose and way of administration
Carp H. 
Progesterone use in recurrent miscarriage
17:00 - 19:00
THE BREAST AS A HORMONAL TARGET IN PHYSIOLOGY AND DISEASE
von Schoultz B. 
Principles for individual variations in the breast response to hormonal treatments
Sismondi P. 
Antihormones in prevention and treatment of breast cancer
 
Quattro
11:00 - 13:00
ORAL PRESENTATIONS - GYNECOLOGICAL CANCERS: THE ROAD AHEAD
Zervoudis S. 
Cross talk between signaling pathways and the development of chemoresistance in breast cancer
Fu X. 
The effects of progesterone and medroxyprogesterone acetate on moesin activation and rapid actin cytoskeleton remodelling in human endothelial cells and t-47-d breast cancer cells
Miyamoto T. 
Mismatch repair activity is accelerated by estrogen stimulation in normal and malignant endometrial glandular cells
Nowak-Markwitz E. 
Co-expression of hCGß and LH/hCG receptor in epithelial ovarian cancer cells
Huser M. 
Gonadal protection with CNRh analogues during chemotherapy ? cytotoxic dose derived cohort study (Ovaronko)
14:00 - 16:00
ORAL PRESENTATIONS - MENOPAUSAL SYNDROME: BIOLOGICAL BASIS
Hestiantoro A. 
Neurons surrounded by basket-like estrogen receptor (ER)β containing terminals in the hypothalamic infundibular nucleus are not affected by neurofibrillary Alzheimer's disease pathology
Mannella P. 
Estrogen Receptor Protein Interaction with PI3K Leads to Activation of pAkt and pERK1/2 in the Same Population of Cortical Neurons: A Unified Mechanism of Estrogen-Action
Bogusiewicz M. 
Influence of estrogen receptor α polymorphism on serum levels of vascular cell adhesion molecule-1 and intercellular adhesion molecule-1 in postmenopausal women taking tibolone or raloxifen - preliminary study
Stomati M. 
Effects of low-dose oral deydroepiandrosterone (DHEA) in postmenopausal women
Milan A. 
Baroreflex sensitivity in post-menopausal hypertensive women is reduced according to central fat distribution
Drews K. 
The significance of calcitonin receptor polymorphism in postmenopausal women
Pluchino N. 
Progesterone and medroxyprogesterone acetate effects on central and peripheral allopregnanolone and beta-endorphin levels
Hayashida S. 
Hepatic function with cimicifuga racemosa in postmenopausal patients
Lenzi E. 
Effect of MAP and Dydrogesterone administration on central and peripheral content of allopregnanolone and beta-endorphin
Tempone A. 
 
Verde
08:30 - 10:00
CHRONIC ANOVULATION IN BODY WEIGHT DISTURBANCES
Brambilla F. 
Psychoneuroendocrine aspects of amenorrhea in anorexia nervosa
Casanueva F. 
The role of leptin and ghrelin in the regulation of gonadal function
Shoham Z. 
Reproductive outcome in women with body weight disturbances
Lello S. 
Estrogens and progestins as a prevention and treatment option in body weight disturbances in women
10:10 - 10:40
MERCK THERAMEX SPONSORED LECTURE - MARC ESPIE: MISSION STUDY : INITIAL RESULTS ON THE PREVALENCE OF BREAST CANCER
Espie M. 
MISSION Study : initial results on the prevalence of breast cancer
14:00 - 16:00
MENORRHAGIA AND ABNORMAL UTERINE BLEEDINGS
Scarselli G. 
Abnormal uterine bleeding: diagnosis and treatment
Sturdee D. 
The merits of intrauterine progestogen
Laudanski T. 
Bleeding pattern and myometrial contractility - pathophysiology and new treatment strategies in dysmenorrhoeic patients
Druckmann R. 
Progestins in menorrhagia and abnormal uterine bleedings
17:00 - 19:00
HYPOTHALAMIC AMENORRHEA
Berga S. 
Brain signals mediating stress-induced anovulation
Genazzani A.D. 
Endocrine and neuroendocrine diagnostic tools for the assessment of stress induced amenorrhea
Rickenlund A. 
Hypothalamic amenorrhea-its relation to physical exercise and sport
Filicori M. 
Treatment of infertility in hypothalamic amenorrhea
Schenker J. 
Prolactinomas, clinical manifestations and treatment
 
05/03/2006
Auditorium
08:30 - 10:30
SEX STEROIDS AND THE CARDIOVASCULAR SYSTEM
Lobo R. 
Body mass, adipocytokines and cardiovascular risk in polycystic ovary syndrome (PCOS)
Stevenson J. 
Cardiovascular health after menopause: lessons learnt for clinical practice
Agnusdei D. 
SERMs and cardiovascular system
10:00 - 11:00
OPENING CEREMONY - OPENING LECTURE BY PROF LEON SPEROFF: THE FUTURE OF POSTMENOPAUSAL HORMONE THERAPY IT'S TIME TO MOVE FORWARD
Speroff L. 
The Future of Postmenopausal Hormone Therapy It's Time to Move Forward
11:30 - 13:30
THE CLIMACTERIC WOMAN: TREATMENT OPTIONS IN 2006
Birkhaeuser M. 
Biological basis and clinical approach to climacteric symptoms
Palacios S. 
Perspectives of the new SERMs
Brincat M. 
Inter-vertebral disc space in the menopause and HRT
Schneider H. 
The role of androgens and antiandrogens
Pines A. 
Hormone replacement in 2006: where do we stand?
Neves-e-Castro M. 
What has experience taught us
 
Onice
08:30 - 10:30
ORAL PRESENTATIONS - RECURRENT ABORTION AND HIGH-RISK PREGNANCY IN THE THIRD MILLENNIUM
Ginocchini L. 
Recurrent pregnancy loss, new orizons
Bagchi M. 
C/EBP Beta is a Critical Mediator of Steroid Hormone-Regulated Cell Proliferation and Differentiation in the Uterine Epithelium and Stroma
Hardman B. 
Insulin Regulates Copper Transporters in Human Placenta: A Novel Role for this Hormone in the Regulation of Copper Transport During Pregnancy
Stefanidis K. 
Oxytocin receptor and TRA-1-81 antigen expression in amniotic fluid cells
Parizek A. 
Serum free and conjugated 20-hydroxy-derivatives of pregnenolone, progesterone and their neuroactive reduced metabolites in the third trimester of human pregnancy
Stjernholm Y.V. 
Mitogen activated protein kinase signaling pathways are activated in human uterine cervix at parturition
Costantino M. 
Alexithymia and biopsychological functions in a large group of pregnant women from southern italy: is there a direct relation with fetal heart rate and variability?
Nasiri Amiri F. 
The Sexual Behavior Associated With Urinary Tract Infection in Pregnant Women
11:30 - 13:30
ORAL PRESENTATIONS - MOLECULAR ENDOCRINOLOGY OF WOMEN
Aghajanova L. 
Functional thyroid hormone receptors are present in human ovarian tissue
Kluft C. 
Estrogen receptor-1 genotypes do not influence baseline levels of hemostasis and lipid risk markers for cardiovascular disease in young women
Begliuomini S. 
Changes of Brain-Derived Neurotrophic Factor throughout ovarian cycle: does it exist a relationship with sex hormonal variations?
Limpaphayom K. 
Urogynecology in Menopause : Prevalence of lower urinary tracts symptoms (LUTS)
Kovács K. 
Differential expression of Forkhead (FKHR) transcription factors in human endometrium and myometrium
 
PalazzoAffari
08:30 - 10:30
ASSISTED REPRODUCTION: PHARMACOLOGICAL AND TECHNICAL APPROACHES FOR SAFETY AND FERTILITY PRESERVATION
Artini P. 
Growth factors and follicologenesis in PCO patients
Devoto L. 
Human corpus luteum function in assisted reproduction
Szamatowicz M. 
"Theft" of the reproductive time of women as a result of unproper treatment of infertility
Papanikolaou E. 
Early progesterone rise in the follicular phase in IVF cycles and impact on the pregnancy outcome
Lewin A. 
Oocytes donation - a model for the study of factors related to oocyte-sperm interaction, embryo quality and implantation
11:30 - 13:30
CURRENT TRENDS IN CONTRACEPTION
Fruzzetti F. 
Estro-progestin Contraception
Lachowsky M. 
What contraception means to adolescents
Spinola P. 
Long-lasting contraception
Siseles N. 
Perimenopausal contraception
Ho P. 
Emergency contraception
Anderson R. 
Male contraception
 
Verde
08:30 - 10:30
ORAL PRESENTATIONS - PCOS: FROM THE BENCH TO THE BEDSIDE
Maher J. 
Characterization of Fem1 expression in the ovary
Ferraz M. 
Polymorphism of the insulin receptor gene in brazilians patients with the polycystic ovary syndrome and hiperandrogenism, insulin resistance and acantosis nigricans (HAIR-AN syndrome)
Spritzer P. 
Calpain-10 gene UCSNP-43 and UCSNP-19 polymorphisms in polycystic ovary syndrome (PCOS)
Pellatt L. 
Anti-müllerian hormone (amh) production was significantly increased in anovulatory polycystic ovaries compared to normal ovaries: role of amh in regulating follicle selection?
Villa P. 
Relevance of ovarian volume in ultrasound diagnosis of pcos in adolescence
Szilagyi A. 
Three dimensional (3D) ultrasound in patients with polycystic ovary syndrome (PCOS); effects of metformin treatment on ovarian volume and blood flow
Nilas L. 
Polycystic ovary syndrome (PCOS), insulin resistance (IR), clinical or biochemical hyperandrogenism is not associated with alterations in bone mass density (BMD)
Seaman H. 
The risk of venous thromboembolism amongst women with polycystic ovary syndrome
11:30 - 13:30
SPECIAL SYMPOSIUM SIERR - ART: LESSONS FROM THE OOCYTE
Lanzone A. 
Intraovarian dysregulation of follicle maturation
Ebner T. 
The predictive value of basal anti-Müllerian hormone (AMH) on oocyte quality and further development
Focarelli R. 
A multidisciplinary approach to the evaluation of the cryopreserved versus fresh human oocyte
 

   home   |   progetto   |   chi siamo   |   servizi   |   contatti   |   note legali

Tuttocongressi ©1995 - 2018 | Via Dei Perfetti Ricasoli, 94-96 - 50127 Firenze  |  P.Iva 03755090481